ATE126054T1 - Entzündungshemmende arzneimittel zur äusserlichen anwendung. - Google Patents

Entzündungshemmende arzneimittel zur äusserlichen anwendung.

Info

Publication number
ATE126054T1
ATE126054T1 AT90312313T AT90312313T ATE126054T1 AT E126054 T1 ATE126054 T1 AT E126054T1 AT 90312313 T AT90312313 T AT 90312313T AT 90312313 T AT90312313 T AT 90312313T AT E126054 T1 ATE126054 T1 AT E126054T1
Authority
AT
Austria
Prior art keywords
external use
inflammatory drugs
alkyl
ability
preparation
Prior art date
Application number
AT90312313T
Other languages
English (en)
Inventor
Francisco Jose Evarist Stefano
Jorge Adrian Nowogrodski
Dario Norberto Ramon Carrara
Original Assignee
Beta Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beta Pharm Co filed Critical Beta Pharm Co
Application granted granted Critical
Publication of ATE126054T1 publication Critical patent/ATE126054T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT90312313T 1989-11-14 1990-11-12 Entzündungshemmende arzneimittel zur äusserlichen anwendung. ATE126054T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AR31543389 1989-11-14

Publications (1)

Publication Number Publication Date
ATE126054T1 true ATE126054T1 (de) 1995-08-15

Family

ID=3478737

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90312313T ATE126054T1 (de) 1989-11-14 1990-11-12 Entzündungshemmende arzneimittel zur äusserlichen anwendung.

Country Status (7)

Country Link
EP (1) EP0428352B1 (de)
JP (1) JPH03275621A (de)
AT (1) ATE126054T1 (de)
BR (1) BR9005878A (de)
DE (1) DE69021511T2 (de)
DK (1) DK0428352T3 (de)
ES (1) ES2083437T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3190441B2 (ja) * 1992-07-20 2001-07-23 エーザイ株式会社 塩酸アゼラスチンを含有する安定な製剤
HU209518B (en) * 1992-12-23 1994-06-28 Egyt Gyogyszervegyeszeti Gyar Process for production of free of skin damaging effect unguent preparation containing piroxicam
JP4181232B2 (ja) * 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
KR19990026792A (ko) 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
AU2189499A (en) * 1998-02-09 1999-08-23 Chong Kun Dang Pharmaceutical Corp. Piroxicam-containing hydroalcoholic gel composition
CA2330435A1 (en) * 1998-04-28 1999-11-04 Aggelos Nikolopoulos Process for the preparation of aceclofenac
JP2000143540A (ja) * 1998-11-06 2000-05-23 Bristol Myers Squibb Co 非ステロイド系消炎鎮痛薬含有外用剤
DE102007034976A1 (de) 2007-07-26 2009-01-29 Bayer Healthcare Ag Arzneimittel zur transdermalen Anwendung bei Tieren
CN111432802A (zh) 2017-12-04 2020-07-17 强生消费者公司 含有非甾体抗炎药的局部用乳液组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837025A (en) * 1988-03-25 1989-06-06 Laboratoires D'hygiene Et De Dietetique Self-adhesive device for the percutaneous administration of an active ingredient

Also Published As

Publication number Publication date
DE69021511T2 (de) 1996-11-21
ES2083437T3 (es) 1996-04-16
DK0428352T3 (da) 1995-12-27
BR9005878A (pt) 1991-09-24
DE69021511D1 (de) 1995-09-14
JPH03275621A (ja) 1991-12-06
EP0428352B1 (de) 1995-08-09
EP0428352A1 (de) 1991-05-22

Similar Documents

Publication Publication Date Title
ATE53301T1 (de) Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung.
BR1100860A (pt) Composto, droga antiinflamatória, composição farmacêutica, epìmero r e epìmero s do composto
FI893520A0 (fi) Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi
IL122208A0 (en) Sidechain-bearing taxanes methods for the preparation thereof and pharmaceutical compositions containing them
DE3786316D1 (de) Ueberzugsmembran und damit hergestellte mittel.
HUT46654A (en) Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient
ES2071621T3 (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
FI931031A0 (fi) Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar
EP0266992A3 (de) Verhütung von glukocorticoid-induzierter Hautatrophie
DE69021511T2 (de) Entzündungshemmende Arzneimittel zur äusserlichen Anwendung.
DK0400522T3 (da) Fremgangsmåde til fremstilling af mikroniserede bionedbrydelige partikler
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
DK99987A (da) Oestrogenpraeparater
CA2136071A1 (en) 2-arylpropionic acid compositions and process for preparing the same
NO873514L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
IS1678B (is) Aðferð til framleiðslu á lyfjablöndu gegn hálskirtlabólgu
PT87031A (pt) Process for the preparation of 4-phenylpiperidine compounds an d of pharmaceutical compositions therewith
DE2965364D1 (en) Alpha-difluoromethyl amino acids and pharmaceutical composition containing the same
NO903291D0 (no) Renin-hemmende aminooligohydroksy-derivater.
DE68914175D1 (de) Parfümgrundzusammenstellung enthaltendes 2-cyclohexylpropanal und Verfahren zur Herstellung dieser Verbindung.
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
NO164773C (no) Analogifremgangsmaate for fremstilling av forbindelser medfarmasoeytisk virkning.
PT86837A (pt) Process for the preparation of novel heterocyclyl-2-propin-1-amines useful as dopamine beta-hydroxylase and of pharmaceutical compositions containing the same
DE58906520D1 (de) Neue 6-Phenoxymethyl-4-hydroxytetrahydropyran-2-one und 6-Thiophenoxymethyl-4-hydroxytetrahydropyran-2-one, sowie die entsprechenden Dihydroxycarbonsäurederivate, Salze und Ester, Verfahren zur Herstellung dieser Verbindungen, ihre Verwendung als Arzneimittel, pharmazeutische Präparate und neue Phenole sowie Thiophenole.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee